Ainhoa Alvarez Ruiz de Larrinaga

Dr. Ainhoa Alvarez Ruiz de Larrinaga

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
LCLaura Cànaves-Gómez
Laura Cànaves-Gómez
AFAarne Fleischer
Aarne Fleischer
JMJosep Muncunill-Farreny
Josep Muncunill-Farreny
PCPaloma Giménez Carrero
Paloma Giménez Carrero
ALAinhoa Alvarez Ruiz de Larrinaga
Ainhoa Alvarez Ruiz de Larrinaga
AFAlberto Alonso Fernandez
Alberto Alonso Fernandez
Obstructive sleep apnea (OSA) is quite prevalent during pregnancy and is associated with adverse perinatal outcomes, but its potential influence on fetal development remains unclear. This study investigated maternal OSA impact on the fetus by analyzing gene expression profiles in whole cord blood (WCB). Ten women in the third trimester of pregnancy were included, five OSA and five non-OSA cases. WCB RNA expression was analyzed by microarray technology to identify differentially expressed genes (DEGs) under OSA conditions. After data normalization, 3238 genes showed significant differential expression under OSA conditions, with 2690 upregulated genes and 548 downregulated genes. Functional enrichment was conducted using gene set enrichment analysis (GSEA) applied to Gene Ontology annotations. Key biological processes involved in OSA were identified, including response to oxidative stress and hypoxia, apoptosis, insulin response and secretion, and placental development. Moreover, DEGs were confirmed through qPCR analyses in additional WCB samples (7 with OSA and 13 without OSA). This highlighted differential expression of several genes in OSA (EGR1, PFN1 and PRKAR1A), with distinct gene expression profiles observed during rapid eye movement (REM)-OSA in pregnancy (PFN1, UBA52, EGR1, STX4, MYC, JUNB, and MAPKAP). These findings suggest that OSA, particularly during REM sleep, may negatively impact various biological processes during fetal development.

14 January 2026 in Sleep Medicine Reviews
Verified
Journal Article
Closed access
ALAinhoa Alvarez Ruiz de Larrinaga
Ainhoa Alvarez Ruiz de Larrinaga
JUJorge Ullate
Jorge Ullate
CPCarla Pía
Carla Pía
ADAngela L. D'ROzario
Angela L. D'ROzario
CECarlos Egea-Santaolalla
Carlos Egea-Santaolalla
MSMaria Comas Soberats
Maria Comas Soberats

1 January 2022 in Revista De Neurologia
Verified
Journal Article
Open access
ALAinhoa Alvarez Ruiz de Larrinaga
Ainhoa Alvarez Ruiz de Larrinaga
JVJuan José Agustí Visiedo
Juan José Agustí Visiedo
MCMª Jesús Valiño Colas
Mª Jesús Valiño Colas
MRMª del Pilar Cuartero Ríos
Mª del Pilar Cuartero Ríos
OSOdile Romero Santo-Tomás
Odile Romero Santo-Tomás

Verified
Journal Article
Open access
PDF file
LCLaura Cànaves-Gómez
Laura Cànaves-Gómez
PCPaloma Giménez Carrero
Paloma Giménez Carrero
ALAinhoa Alvarez Ruiz de Larrinaga
Ainhoa Alvarez Ruiz de Larrinaga
ABAndrés Sánchez Baron
Andrés Sánchez Baron
MMMercedes Codina Marcet
Mercedes Codina Marcet
AFAlberto Alonso Fernandez
Alberto Alonso Fernandez
Obstructive sleep apnea (OSA) is common during pregnancy and linked to adverse outcomes. While oxidative stress is a proposed pathogenic mechanism, evidence in pregnant populations remains limited. This multicenter, prospective study evaluated oxidative stress through protein carbonyl levels in 171 pregnant women and 86 cord blood samples. Polysomnography (PSG) performed during pregnancy categorized participants with the apnea–hypopnea index (AHI) in OSA, rapid eye movement (REM) OSA, and supine OSA. Protein carbonyl levels were measured by the dinitrophenyl hydrazine (DNPH) method. No significant differences were found in maternal or cord blood protein carbonyl levels between OSA and non-OSA groups, or between REM and supine OSA subgroups. Interestingly, women with shorter apnea–hypopnea (AH) length showed both higher maternal and cord blood protein carbonyl levels and lower nocturnal oxygen saturation. Overall, OSA in pregnancy was not associated with increased oxidative stress as measured by protein carbonyl levels. However, apnea–hypopnea duration and nocturnal hypoxia may influence oxidative stress, pointing to a complex relationship between OSA and oxidative stress during pregnancy, beyond traditional metrics like AHI. Future studies should explore additional biomarkers and diverse molecular pathways that could play a role, with special attention to emerging factors such as apnea–hypopnea length and hypoxic burden to elucidate the interrelationships between OSA and pregnancy more comprehensively.

14 April 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MFMarcos Fernández-Barriales
Marcos Fernández-Barriales
MLMontserrat López de Luzuriaga
Montserrat López de Luzuriaga
IMIrene Lafuente Ibáñez de Mendoza
Irene Lafuente Ibáñez de Mendoza
JFJuan Julián Alonso Fernández-Pacheco
Juan Julián Alonso Fernández-Pacheco
ALAinhoa Alvarez Ruiz de Larrinaga
Ainhoa Alvarez Ruiz de Larrinaga
JUJosé Manuel Aguirre Urizar
José Manuel Aguirre Urizar
Background/Objectives: In our previous systematic review, we found no convincing evidence to support rapid maxillary expansion (RME) as a treatment for pediatric obstructive sleep apnea (OSA). Subsequent clinical guidelines and expert opinion have continued to recommend this orthodontic treatment. We aimed to update our search to determine whether new controlled prospective evidence alters this conclusion. Methods: We updated our previous systematic review, searching for controlled prospective studies on RME efficacy for pediatric OSA published up to 1st February 2026. Results: Three new randomized clinical trials (RCTs) were identified in addition to the five original studies. Critically, none of the new RCTs included a watchful waiting or supportive care control arm, leaving the sole available comparison against watchful waiting unchanged: a single RCT that found no significant difference in AHI change between RME and observation. Of the remaining new RCTs, two found marginal AHI improvement with RME and one found no significant AHI reduction. Conclusions: The observed AHI improvements in studies lacking an untreated comparator cannot be distinguished from the known potential for spontaneous improvement in growing children. Extreme caution is warranted before recommending RME as a treatment for pediatric OSA.

12 August 2026 in Clocks & Sleep
Verified
Journal Article
Open access
PDF file
ALAinhoa Alvarez Ruiz de Larrinaga
Ainhoa Alvarez Ruiz de Larrinaga
JUJorge Ullate
Jorge Ullate
AHAlejandro Horrillo-Maysonnial
Alejandro Horrillo-Maysonnial
CPCarla Pía
Carla Pía
CECarlos Egea
Carlos Egea
MSMaria Comas Soberats
Maria Comas Soberats
Background: Obstructive sleep apnea (OSA) has been implicated in declarative memory impairment. Here, we evaluated immediate recall and overnight declarative memory in patients with suspected OSA before and after standard clinical management in a longitudinal cohort of 265 patients. Methods: A nocturnal polysomnographic study (PSG) was performed at baseline and repeated six months later. The Pictorial-Based Declarative Memory Questionnaire (PDMQ) was administered and consisted of four learning trials followed by free-recall 10 min before PSG and the following morning upon awakening. The primary cognitive endpoint was the change in pictorial declarative memory performance from baseline to 6-month follow-up, expressed as the number of correctly recalled items on the PDMQ. Results: Both immediate and delayed recall performances significantly improved in the no OSA/mild OSA and severe OSA groups, whereas only immediate recall improved in the moderate OSA group. In the severe group, comparisons between patients whose apnea–hypopnea index decreased to 30 revealed significant cognitive improvements in both subgroups, particularly in initial and late trials (Trials 1, 2, 5, 6). In multivariable models, baseline PDMQ performance and indices of SpO2 desaturation and sleep fragmentation emerged as independent predictors of change in declarative memory. Conclusions: These findings suggest that routine clinical management of patients with OSA was accompanied by modest, albeit statistically significant improvements in declarative memory, and that both intermittent hypoxia and sleep fragmentation play important roles in memory change.